Morningside Ventures led a $27.5m Series B Funding round in Curai Health.

Morningside Ventures, a private equity firm, led a $27.5m Series B Funding round in Curai Health, a virtual care company. General Catalyst Partners and Khosla Ventures also participated. "Primary care should be just that -- primary -- to every single person, but without drastic innovation, the current system will only create more scarcity, higher costs and a sicker population. AI has the power to scale the care provided by a finite number of physicians so that it can meet the demands of a global population. We've dedicated countless hours to in-depth clinical and technical R&D to ensure our system gets smarter, more efficient and increasingly cost-effective after every patient encounter. We aren't interested in the 10- to 20% cost savings that most virtual care platforms aspire to deliver. We're working toward 10 and, eventually 100x, care-delivery cost reductions," Neal Khosla, Curai Health co-founder and CEO.